Results 171 to 180 of about 178,200 (246)
Diastolic Dysfunction with Vascular Deficits in HIV-1-Infected Female Humanized Mice Treated with Antiretroviral Drugs. [PDF]
Alomar FA+8 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala+1 more
wiley +1 more source
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio+12 more
wiley +1 more source
Incidence and Progression of Diastolic Dysfunction in People With HIV in Tanzania: A Comparative Cohort. [PDF]
Cichowitz C+17 more
europepmc +1 more source
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau+12 more
wiley +1 more source
Left ventricular diastolic dysfunction in non-myocardial disorders. [PDF]
Smiseth OA+3 more
europepmc +1 more source
The figure illustrates the study design and key findings related to right ventricular myocardial work (RVMW) in heart failure with reduced ejection fraction (HFrEF) patients with and without pulmonary hypertension (PH). Patients were stratified into two groups: those with PH (n = 53) and those without PH (n = 49), as determined by right heart ...
Paolo Manca+12 more
wiley +1 more source
Relationship between serum uric acid and ventricular diastolic dysfunction in type 2 diabetes mellitus patients. [PDF]
Chen W+5 more
europepmc +1 more source
Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia+13 more
wiley +1 more source